相关实验视频

Updated: Jun 12, 2025

Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice
04:10

Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice

Published on: March 31, 2023

4.4K

在重症喉沙丘病中使用JAK抑制剂托法西提尼布:病例报告

Meryem Demir1,2, Vasileios Kouranos1, Kostadin Stoenchev1

  • 1Royal Brompton Hospital London, Guy's, and St Thomas' NHS Foundation Trust, London, UK.

The Laryngoscope
|September 19, 2024
PubMed
概括

托法西提尼布是一种简氏激酶 (JAK) 抑制剂,有效地治疗了对其他疗法的耐药性患者的重症多系统性沙丘病. 这种治疗改善了肺,皮肤和喉症状,避免了气管切开术.

关键词:
雅克-斯塔特 (JAK-STAT) 是一个这是一种JAK抑制剂.喉 Sarcoidosis 喉 Sarcoidosis 喉 喉 喉 喉 喉 喉这种类型的麻症是有毒的.托法西提尼布 (tofacitinib) 是一种

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-308:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.0K
A Heterotopic Mouse Model for Studying Laryngeal Transplantation14:15

A Heterotopic Mouse Model for Studying Laryngeal Transplantation

Published on: January 13, 2023

2.8K

相关概念视频

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K